Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum

Journal of Biochemistry
Y YatomiS Kume

Abstract

Although sphingosine 1-phosphate (Sph-1-P) is reportedly involved in diverse cellular processes and the physiological roles of this bioactive sphingolipid have been strongly suggested, few studies have revealed the presence of Sph-1-P in human samples, including body fluids and cells, under physiological conditions. In this study, we identified Sph-1-P as a normal constituent of human plasma and serum. The Sph-1-P levels in plasma and serum were 191+/-79 and 484+/-82 pmol/ml (mean+/-SD, n=8), respectively. Furthermore, when Sph-1-P was measured in paired plasma and serum samples obtained from 6 healthy adults, the serum Sph-1-P/plasma Sph-1-P ratio was found to be 2.65+/-1.26 (mean+/-SD). It is most likely that the source of discharged Sph-1-P during blood clotting is platelets, because platelets abundantly store Sph-1-P compared with other blood cells, and release part of their stored Sph-1-P extracellularly upon stimulation. We also studied Sph-1-P-related metabolism in plasma. [3H]Sph was stable and not metabolized at all in plasma, but was rapidly incorporated into platelets and metabolized mainly to Sph-1-P in platelet-rich plasma. [3H]Sph-1-P was found to be unchanged in plasma, revealing that plasma does not contain the ...Continue Reading

Citations

Apr 26, 2001·Journal of Physiology and Biochemistry·J RiveraV Vicente
Aug 2, 2011·Seminars in Immunopathology·Hideru Obinata, Timothy Hla
Jan 14, 2009·Basic Research in Cardiology·Voahanginirina RandriamboavonjyIngrid Fleming
Jan 20, 2004·Biochimica Et Biophysica Acta·Yusuke NakadeTakashi Murate
May 26, 2004·Biochimica Et Biophysica Acta·Tarek A TahaLina M Obeid
Jan 7, 2004·Neuroscience·B J SeguraM W Mulholland
Jun 5, 2003·European Journal of Pharmacology·Salvatore SalomoneChristian Waeber
Sep 3, 1998·European Journal of Pharmacology·D Meyer zu HeringdorfK H Jakobs
Jan 21, 2004·The Journal of Surgical Research·B J SeguraM W Mulholland
Apr 28, 2001·Prostaglandins & Other Lipid Mediators·Y YatomiY Igarashi
May 9, 2000·Progress in Lipid Research·N AugéT Levade
Mar 6, 2003·Cellular Signalling·Markus FuellerWolfgang Siess
Apr 5, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Benedetta CinqueM Grazia Cifone
Apr 13, 2000·Biochimica Et Biophysica Acta·S Spiegel, S Milstien
Jun 19, 2002·Biochimica Et Biophysica Acta·Wolfgang Siess
Jun 19, 2002·Biochimica Et Biophysica Acta·Joel S Karliner
Jun 19, 2002·Biochimica Et Biophysica Acta·Maria Laura Allende, Richard L Proia
Apr 20, 2001·British Journal of Pharmacology·A BischoffM C Michel
Jul 6, 2000·The Biochemical Journal·S Pyne, N J Pyne
Dec 3, 1999·British Journal of Haematology·L YangY Ozaki
Jun 18, 2009·The Journal of Biological Chemistry·Naoki KobayashiTsuyoshi Nishi
Nov 21, 2012·The Journal of Experimental Medicine·Timothy HlaRalph Nachman
Apr 10, 1999·Molecular Biology of the Cell·C H LiuT Hla
Mar 7, 2008·Molecular Biology of the Cell·Miguel Miron-MendozaFrederick Grinnell
Mar 14, 2009·Cardiovascular Research·Christopher K Means, Joan Heller Brown
Aug 22, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angelo M Scanu, Celina Edelstein
Mar 4, 2005·Clinical and Experimental Pharmacology & Physiology·Tay Hwee KeeAlirio J Melendez
Jun 17, 2008·Pharmacological Reviews·Kazuaki TakabeSarah Spiegel
Jun 11, 2004·Annual Review of Biochemistry·Isao IshiiJerold Chun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.